Introduction
Glucocorticoid hormones are essential for life. They play a regulatory role in tissue differentiation during development. In the adult organism, they control intermediary metabolism and co-ordinate the adjustment of physiological processes in response to stress (for a review, see Baxter & Rousseau, 1979) .
In target cells, glucocorticoids bind noncovalently and reversibly to about 25000 intracellular receptor sites. These sites are borne by a thermodynamically homogeneous population of oligomeric phosphoproteins. The receptor is found Abbreviations used: MTV, mouse mammary tumour virus; bp, base pairs; LTR, long terminal repeat; GRE, glucocorticoid response element; TIE, transcription initiation element.
in the cytosol when the steroid is absent (as discussed later, this does not prove that, in intact cells, steroid-free receptors are located in the cytoplasm). Binding of a glucocorticoid agonist is thought to promote dissociation and dephosphorylation of the receptor. This process, called 'activation' or 'transformation', enables the steroid-receptor complex to become associated with chromatin in the cell nucleus. The biochemical mechanisms of this nuclear transfer are unknown. One way in which glucocorticoid antagonists act is by binding to the receptor to form a complex that cannot undergo the 'transformation' process ( Fig. 1) .
The receptor monomer contains a single polypeptide chain of Mr 90000. The steroid-(one per monomer) and DNA-binding sites occur on a receptor region no greater than about half the AGONIST JTAI(-.nPJICTx Fig. 1 . First steps in glucocorticoid hormone action The figure shows an idealized target cell in which glucocorticoid agonists (small squares) or antagonists (small circles) penetrate rapidly and combine reversibly with the glucocorticoid receptor to form an active (Ra) or inactive (Ri) complex. In order to interact with chromatin, the receptor-agonist complex must become 'transformed' (R), a step that probably involves dephosphorylation (P). The possibility that all the intracellular steps described actually occur within the nucleus has not been entirely discounted (see the text for discussion).
Vol. 224 molecule. The other half is called the 'specifier' region because it is required for receptor action (Vedeckis, 1983) .
Most of the glucocorticoid effects amenable to experimentation have been shown to result from a receptor-mediated change in concentration or activity of key proteins. This change is a consequence of an action of the receptor-steroid complex on the molecular machinery that controls gene expression. Recent advances such as recombinant-DNA and monoclonal-antibody techniques have offered new ways of exploring this machinery. Since the glucocorticoid receptor qualifies as one of the few proteins known to control gene expression in eukaryotes, it is not surprising that glucocorticoids have become a fashionable tool for the molecular biologist.
In this Review I will attempt, by relying largely on the current literature, to review the progress in the field and to show how the study of glucocorticoid hormone action has shed a new light on important biochemical tissues that can be as remote from endocrinology as transcriptional control or retrovirus expression.
Glucocorticoids modulate mRNA concentration
A physiological consequence of the formation of a glucocorticoid-receptor complex in the intact cell is an increase or a decrease in the amount of a small number of gene products (less than 1%) that are specified by the differentiation of the cell (Ivarie et al., 1980; Voris & Young, 1981) . Depending on the so-called 'glucocorticoid domain' of the target cell, such gene products include enzymes (tyrosine aminotransferase), 'house-keeping' proteins (metallothionein), structural proteins (fibronectin, collagen), membrane hormone receptors (insulin receptor), secretory proteins (casein, a2l-globulin), hormones (somatotropin), or even retroviruses such as the mouse mammary tumour (Bittner) virus (MTV).
The activity or concentration of those gene products changes as a result of changes in the concentration of their own mRNA (Table 1) , or of the mRNA of regulatory factors which, in turn, control the activity of the gene products. These regulatory factors often remain unidentified. Their involvement is postulated when the glucocorticoidinduced change in enzyme activity results from a change in the properties of enzyme molecules, as is the case for the inhibition of plasminogen activator (Coleman et al., 1982) . Another example is induction of alkaline phosphatase, which has been ascribed, at least in part, to a glucocorticoidinduced dephosphorylation mechanism (Cox & Elson, 1971) . Glucocorticoid-induced intermediates should also be suspected when the lag period (Rousseau et al., 1980) , but becomes detectable long after induction of tyrosine aminotransferase, a transcriptional effect, has taken place (Fig. 2) .
In some cases, ongoing protein synthesis is required for the full glucocorticoid effect on mRNA to be seen. Cycloheximide abolishes in rat liver cells the induction of a2u-globulin (Chen & Feigelson, 1979) and of phosphoenolpyruvate carboxykinase (Iynedjian & Jacot, 1981) mRNA; it reduces the accumulation of a 1-acid glycoprotein mRNA (Feinberg et al., 1983) . In rat glial cells, the glucocorticoid-induced accumulation of mRNA for glycerol phosphate dehydrogenase-is inhibited by cycloheximide (McGinnis & de Vellis, 1978 (Firestone et al., 1982) .
Whether they account directly or indirectly for the observed changes at the protein level, the receptor-induced changes in mRNA concentration could, theoretically, result from transcriptional or (and) post-transcriptional effects. Although they have not been ruled out, direct effects of the glucocorticoid-receptor complex on the translational or post-translational machinery remain to be demonstrated. For instance, glucocorticoids inhibit both the transcription (Mierendorf & Mueller, 1982) and the translation (Papaconstantinou et al., 1983) (Rousseau et al., 1980) The most popular model has been the MTV (Fig.  3) , the transcription of which can be stimulated rapidly (15 min) and up to 100-fold by glucocorticoids (Ringold et al., 1977b) , independently of protein synthesis (for a review, see Groner et al., 1983b) . This glucocorticoid effect was retained in non-murine (i.e. exempt from endogenous provirus) cells infected with the virus and expressing it (Ringold et al., 1977a Figure) . This DNA contains at both ends an identical 1328 bp sequence called 'long terminal repeat' (LTR), which may be analogous to bacterial transposons (Finnegan, 1981) . The LTR (Temin, 1981) is made of a unique sequence (-1200bp) copied from the 3' end of the viral RNA (U3), a unique sequence (120 bp) from the 5' end of the viral RNA (U5), and a sequence (16bp) repeated at both ends of the RNA (R). The first 959bp of U3 could code for an unidentified gene product (orf) of unknown function. The five viral core proteins (group-specific antigens) are encoded in the gag sequence, the reverse transcriptase (RT) is encoded in the pol sequence, and the two envelope proteins are encoded in the env sequence. Replication of the provirus with the genome of the host, where it is normally non-tumourigenic, ensures its vertical transmission. A rare event is the production in mammary gland cells of 70S double-stranded (ds) RNA transcripts which become packaged as 'B particles' containing reverse transcriptase (RT). These milk-borne infectious particles account for the horizontal transmission of the virus. In infected cells (right-hand side), the viral RT catalyses the production of linear and circular dsDNA molecules which cannot be transcribed but are able to integrate in the host genome as single or multiple non-methylated copies. This can lead, via unknown mechanisms, to cellular transformation. The integrated viral DNA can now be transcribed by the host RNA polymerase into viral RNA, a process which is stimulated by glucocorticoids (GC). Viral proteins are produced from the transcribed viral RNA (see Ringold et al., 1978 , for review). The 'transcription initiation element' (TIE), i.e. the viral promoter region (stippled area) which contains the TATA box (at about -30) is within 80bp upstream from the transcription initiation (cap) site. The glucocorticoid-sensitive region, also called 'glucocorticoid response element (GRE), (hatched area) maps in the region -200 to -100, most probably between -190 and -140 (see the text and Groner et al., 1983b) . The MTV box on the right-hand side has been expanded to show the left LTR in more detail. dine kinase (tk)-deficient mouse fibroblasts (tk-L cells) with cloned viral DNA allowed a definition of the glucocorticoid-sensitive viral DNA regions to be made. In these experiments, unintegrated viral DNA from infected hepatoma cells (Buetti & Diggelman, 1981) or proviral DNA from a mouse library (Hynes et al., 1981b) (Fasel et al., 1982) . The LTR contains the viral transcription initiation site (Fig. 3) .
These experiments led to the conclusion that (i) sequences are present within the proviral DNA itself that are required for hormonal induction of MTV transcription; (ii) receptor action appears to stimulate the rate of initiation events from a single pre-existing transcriptional start site within the viral DNA; (iii) a specific subregion (LTR) of the proviral DNA is competent to mediate hormonal regulation upon its re-introduction into cellular genomes by DNA transformation.
Glucocorticoid-sensitive genes other than viral genes have been successfully transferred and induced by the hormone in heterologous, glucocorticoid receptor-positive, cells. The cloned human metallothionein-IIA gene has been introduced into rat fibroblasts and found to retain its responsiveness to both glucocorticoids and heavy metals (Karin & Richards, 1982) . Two rat a2u-globulin genes introduced by co-transfection with the herpes virus-thymidine kinase gene in the tk-L cells were transcribed and expressed as secreted a2u-globulin. Both the mRNA and the protein levels rose in response to the steroid (Kurtz, 1981) . Similar results in the same system were obtained with the rat (Moore et al., 1982) and human somatotropin genes and showed that DNA sequences required for induction reside within 500bp of 5'-flanking DNA (Robins et al., 1982) . Finally, a rat somatotropin gene, possessing at least 2kbp of adjacent cellular sequences at both ends of the coding region, was introduced in mouse NIH-3T3 cells, by using a plasmid vector containing Moloney mouse sarcoma virus. The transformed cells form foci upon infection and can thus be selected. These cells not only expressed rat somatotropin mRNA and secreted mature rat somatotropin, they responded to glucocorticoids by increased somatotropin production (Doehmer et al., 1982 (Hynes et al., 1983) . Thus, the LTR was sufficient to confer glucocorticoid sensitivity to a gene located at its 3'-side. This conclusion confirmed earlier experiments using other glucocorticoid-insensitive genes. Mouse dihydrofolate reductase (dhfr) was expressed and its production was stimulated by glucocorticoids in dhfr-Chinese hamster ovary (CHO) cells transfected with plasmids containing LTR-dihydrofolate reductase recombinant DNA (Lee et al., 1981) . The p21 transformation (ras) gene from Harvey murine sarcoma virus, another glucocorticoid-unresponsive gene, was removed from its normal promoter, linked downstream of the MTV LTR, and introduced into NIH-3T3 cells which became transformed. The levels of p21 RNA and protein were increased in the presence of glucocorticoids (Huang et al., 1981) . It should be noted that retroviral LTRs may behave as strong 'promoters' (in the broad sense) which exhibit the general property of activating, irrespective of glucocorticoid stimulation, the expression of heterologous gene coding sequences from which the natural promoter has been deleted (Joyner et al., 1982) . On the other hand, the lack of glucocorticoid sensitivity of the Rous sarcoma virus (Majors & Varmus, 1983) indicates that not all LTRs are glucocorticoidsensitive. Thus, it was of interest to find that the promoter region of the chicken lysozyme gene, covalently linked to the coding region of the SV40 T antigen, could confer glucocorticoid sensitivity to the expression of this foreign antigen (detected by immunofluorescence) after microinjection into individual chick oviduct cells (Renkawitz et al., 1982) . Similarly, a 500bp sequence of 5'-flanking DNA from the human somatotropin gene rendered the thymidine kinase gene responsive to glucocorticoids (Robins et al., 1982) .
Cell transfection by chimaeric DNA also helped to delineate the DNA regions that confer to genes their glucocorticoid sensitivity. A 'functional' mapping of the MTV LTR was attempted by studying how deletions in this LTR affected expression of LTR-thymidine kinase constructs.
Stepwise deletion of nucleotide sequences 5' to the Vol. 224 viral initiation site, which is within the LTR at about 1200bp from the 5' end, showed that hormonal inducibility of the chimaeric DNA (but not expression of the thymidine kinase gene, which contained its own promoter) was fully retained when only 200bp were left upstream from the initiation site, but was lost when less than 50bp were left (Hynes et al., 1983) . Similar studies with a promoter-less thymidine kinase gene linked to LTR with deleted sequences suggested that the steroid-sensitive region maps between -204 and -105 (Buetti & Diggelman, 1983) or -190 and -140bp (Majors & Varmus, 1983 ) from the initiation site and is distinct from the LTR promoter region which is responsible for the constitutive levels of thymidine kinase expression and which is located downstream from -80 (Fig.  3) . Moreover, regulation was maintained when the latter region was replaced by analogous (but noninducible) Rous sarcoma virus sequences or when the interval between these regions was reduced by 20bp or increased by 4bp (Majors & Varmus, 1983) . Thus one can distinguish, in MTV DNA, a 'glucocorticoid response element' (GRE) which is distinct from the 'transcription initiation element' (TIE). MTV fragments containing the GRE but not the TIE, when fused to a thymidine kinase gene containing its own TIE, conferred to the latter glucocorticoid sensitivity. This activity of GRE persisted even when its location and orientation relative to the thymidine kinase TIE differed from that relative to the MTV TIE (Chandler et al., 1983) . Using a similar approach, Karin et al. (1984) have characterized the DNA sequences through which glucocorticoids and cadmium induce the human metallothionein-IIA gene. Rat fibroblasts were transfected with a chimaeric gene consisting of 800bp of the 5' flanking region, containing the promoter elements, the cap site and the 5' untranslated region of the metallothionein gene, fused to the transcribed portion of the herpes simplex virus-thymidine kinase gene. Transcription from the metallothionein promoter generated a functional thymidine kinase mRNA at levels increased, by a transcriptional mechanism, upon treatment of the transfected cells with either dexamethasone or cadmium. Study of deletion mutants defined three separate regulatory elements. One (-70 to -90 ) is important for maintenance of the basal level of expression; it contains a sequence capable of forming a Z-DNA structure. The second, a dodecameric sequence present in two copies (-38 to -50 and -130 to -150) , is involved in induction by heavy metals. The third is the glucocorticoid-sensitive element and its location (-237 to -268) clearly shows that both types of inducers act at distinct sites on DNA.
Glucocorticoid receptor binds to defined DNA regions Early experiments had shown that the receptor binds to total DNA but had failed to demonstrate preferential binding to specific DNA regions (Rousseau et al., 1975) . This suggested that lowaffinity non-specific DNA binding could preclude detection of a small number of physiologically relevant DNA binding sites, as is the case for prokaryotic transcriptional regulatory proteins (Yamamoto & Alberts, 1976) . The availability of purified receptor, together with the discovery in MTV of defined DNA sequences involved in the glucocorticoid control of gene expression, made it pbssible to re-assess the issue.
DNA-receptor interactions were assayed using nitrocellulose filters which retain double-stranded DNA only if it is protein-bound. Receptor-bound radioactive DNA can be characterized, after elution from the filter, by agarose-gel electrophoresis followed by autoradiography. Glucocorticoidbound receptor purified from rat liver was 'transformed' (see the Introduction) and incubated with radioactive cloned fragments of MTV DNA. Specific receptor binding was detected with LTRcontaining DNA but not with phage or plasmid DNA (Payvar et al., 1981; Govindan et al., 1982) . Experiments with LTR deletion mutants showed that the receptor binding region was restricted to a DNA segment located between 202 and 50bp upstream from the cap (i.e. initiation) site (Scheidereit et al., 1983) . It is precisely within this segment that one finds the GRE defined by the transfection experiments discussed above. DNAbound receptors were visualized by electron microscopy as clusters of putative tetramers occupying discrete regions along the DNA molecule (Payvar et al., 1983) .
The receptor also bound to MTV regions outside the LTR and to mouse genomic sequences flanking endogenous proviral copies (Geisse et al., 1982) . The fact that a 45000 Mr receptor fragment, presumably devoid of the 'specifier' domain (see the Introduction), displayed DNA binding in these experiments casts doubt on the physiological significance of such receptor-DNA interactions. In addition to the receptor-binding region in the LTR upstream from the cap site, four binding regions were detected within transcribed sequences between 4 and 8 kbp downstream from the cap site. The functional significance of these binding sites is unknown (Payvar et al., 1983) . The actual DNA sequences recognized by the receptor were identified by 'footprinting' experiments. Several regions within each of the DNA fragments specifically retained by the receptor were protected by the purified receptor against digestion by deoxyribonuclease I. Recent experiments with the chimaeric metallothionein-thymidine kinase constructs described above showed that the purified rat receptor binds preferentially to, and protects against nuclease digestion, a DNA sequence (-248 to -263) located within the GRE. This sequence has a high degree of homology with two regions (-186 to -170 and -129 to -1 13) of the MTV-LTR that are protected against nuclease digestion (Scheidereit et al., 1983) . A comparison of these segments yields the consensus sequence T(C)GGTA(T)CAA(C)A(T)TGTT(C)CT. This sequence is different from that involved in induction of metallothionein by heavy metals.
Specific binding of purified LTR-containing DNA to the receptor in crude cell extracts could also be shown by using a DNA-cellulose competition assay (Pfahl, 1982) or by 'fishing out' the DNA-receptor complex with an anti-receptor antibody (Scheidereit et al., 1983) . This allowed one to show that inhibition of receptor transformation by molybdate inhibited DNA binding and that mouse receptor mutants deficient in nuclear transfer displayed decreased affinity for DNA.
Mechanisms of receptor action Involvement of the receptor and of the steroid
The molecular mechanism by which glucocorticoids modulate the concentration of mRNAs of specific genes is unknown. A good correlation has been found between nuclear receptor binding and mRNA stimulation, for somatotropin (Samuels et al., 1979) and metallothionein (Mayo & Palmiter, 1981) induction. Furthermore, a glucocorticoid antagonist decreased both the binding of receptors to LTR DNA and the stimulation by glucocorticoids of LTR transcription (Groner et al., 1983a) . These findings strongly suggest that the receptor is directly involved in the glucocorticoid effect.
Whether the steroid itself plays a role other than maintaining the receptor in an 'active' conformation is not known. Models have been put forward (Sluyser, 1983) in which both the receptor and its steroid ligand functionally interact with the genome, as has been proposed for the cyclic AMPcatabolite activator protein (CAP) complex in prokaryotes (Ebright & Wong, 1981) . Such models would predict that some glucocorticoid antagonists might act at the nuclear level by blocking the receptor in an inactive complex with DNA because they cannot contribute properly to the DNA-binding interaction. Indeed, receptors complexed with the antagonists promegestone (Golaz & Beck, 1983) or dexamethasone mesylate (Simons et al., 1983) bind to the nucleus of target cells. In this context, it must be pointed out that the cytosolic localization of the receptor in extracts of steroid-free cells does not prove that the unbound receptor belongs to the cytoplasm in the intact cell. It may well be that the receptor is a nuclear protein which leaks outofthe nucleus upon homogenization in hypo-osmotic buffers, unless it is steroid-bound. Association of the glucocorticoid antagonists with the nucleus would then not be surprising. This view is supported by recent experiments on the oestrogen receptor (for discussion, see Schrader, 1984) . However, immunofluorescence microscopy of intact cells shows that receptors labelled with antireceptor antibodies do actually 'translocate' from the cytoplasm to the nucleus upon association with a glucocorticoid (Govindan, 1980) . Glucocorticoids and oestrogens do not necessarily act through identical molecular and cellular mechanisms. Indeed, the 'transformation' process involves receptor dissociation in the case of glucocorticoids (Vedeckis, 1983; Raaka & Samuels, 1983) and receptor dimerization in the case of oestrogens (Notides et al., 1975) .
In any case, the possibility that all the intracellular events depicted in Fig. 1 do actually occur within the nucleus in intact cells does not challenge the basic 'two-step' model of glucocorticoid action according to which the receptor exists under two distinct states, an inactive conformation (unbound or antagonist-bound receptor) and a 'gene-active' conformation (agonist-bound receptor).
Transcriptional and post-transcriptional effects
The mechanisms of receptor action on mRNA must account for both the transcriptional and the post-transcriptional effects of glucocorticoids. Post-transcriptional processes include capping, methylation, polyadenylation, splicing, cytoplasmic transfer, and turnover of mRNA (Nevins, 1983) . Glucocorticoids stabilize a1-foetoprotein mRNA, despite the fact that they decrease its rate of transcription (Guertin et al., 1983) . They stabilize metallothionein mRNA in HeLa cells transfected with the metallothionein gene . Stabilization of mRNA, in addition to increased transcription, might also account for the increased somatotropin mRNA levels seen in pituitary cells stimulated by glucocorticoids (Lan et al., 1984) . The glucocorticoid-induced increase in casein mRNA levels, seen in mammary glands stimulated with prolactin, seems to involve a posttranscriptional effect (Guyette et al., 1979) .
Most observations, however, are best explained by a transcriptional effect of glucocorticoids, as has been discussed with the MTV paradigm (for a review, see Yamamoto, 1984a) . A kinetic study of the glucocorticoid induction of LTR-thymidine kinase chimaeric constructs (Groner et al., 1983a) showed that initiation of LTR RNA synthesis, absent from hormone-free transfected cells, was simulated within 7.5min after hormone addition. This was independent of protein synthesis, and required a functional steroid-receptor complex since it was inhibited by a glucocorticoid antagonist. The half-life of LTR RNA (30min) was unchanged by dexamethasone. Recent experiments in this system suggest that glucocorticoids affect solely the efficiency of utilization of the MTV promoter, leaving unchanged initiation, splicing, and polyadenylation (Ucker et al., 1983 ). This simple model is contrasting with the more complex mechanism thought to be involved in the regulation by steroid hormones of egg white gene transcription in the chick oviduct .
A transcriptional effect of glucocorticoids might hold true even when mRNA levels are decreased by glucocorticoids. Indeed, kinetic and cell-free transcription experiments on the glucocorticoid inhibition of a1-foetoprotein (Guertin et al., 1983) and of P-globin synthesis (Mierendorf & Mueller, 1982) suggest that the decrease in mRNA levels, which can be observed within 30min following glucocorticoid administration, results from a direct inhibition of transcription, most probably at the initiation step. An inhibition of transcription is also the most likely interpretation of the nearcomplete inhibition of rRNA synthesis seen in cells that undergo mitotic arrest after glucocorticoid treatment (Cavanaugh & Thompson, 1983) . Whether receptor action is transcriptional or post-transcriptional, it could involve a receptorprotein or (and) a receptor-nucleic acid interaction, as is discussed below. Involvement of DNA 'The experiments with MTV and metallothionein-thymidine kinase constructs reported above demonstrate that the receptor can interact with DNA, presumably at sites distinct from the TIE. The results obtained with the latter system clearly show that the glucocorticoid receptor can act as a positive regulatory factor. Indeed, deletion of the GRE, which also contains the receptorbinding site, does not affect the basal level of metallothionein promoter activity or its ability to be induced by heavy metals. The functional and physical relationships of the putative glucocorticoid target (GRE) with the TIE have led to the concept that GREs are 'receptor-dependent transcriptional enhancers' (proto-enhancers) (Chandler et al., 1983; Yamamoto, 1984a) . Enhancers are DNA regions, found in viral and cellular genomes, that increase, through unknown mechanisms, the transcriptional efficiency of genes in a manner relatively independent of their position and orientation with respect to those genes (Khoury & Gruss, 1983) . In this context, receptor action would mediate a change in DNA or (and) chromatin configuration such that its functional consequence is propagated from the GRE to the TIE. No DNA sequences specific to enhancers have been identified yet (Fried et al., 1983) . Still, a 70% consensus sequence lObp long (TXAGXTCTXA) has been found in putative GRE regions for four glucocorticoid-responsive genes: MTV, somatotropin, tryptophan oxygenase, and pro-opiomelanocortin (Buetti & Diggelmann, 1983) .
Recent experiments using cells transfected with chimaeric LTR-thymidine kinase genes (these cells express the thymidine kinase gene) showed that initiation at the LTR cap site in the absence of glucocorticoids required the presence of the two LTRs, as is the case in intact provirus. In constructs containing only one LTR, glucocorticoids both stimulated thymidine kinase transcription and allowed initiation at the LTR cap site, as if the hormone could substitute for the missing, second, LTR (Groner et al., 1983b) . The complexity of glucocorticoid action is further illustrated by the facts that it superimposes to that of viral (SV40 or murine sarcoma) enhancers (Majors & Varmus, 1983) , and that it appears to stimulate transcription of repetitive sequences homologous to the Alu family (Feinberg et al., 1983 ) (Alu sequences are short, repetitive, stretches of DNA that are complementary to sequences found in small cytoplasmic RNAs such as the 7 S RNA component of the 'signal recognition particles').
The receptor-steroid complex could act on DNA by physically perturbing it (e.g. the receptor destabilizes the double helix and facilitates RNA polymerase entry), or by chemically modifying it (e.g. the receptor is an enzyme). Since expressed genes appear to be less methylated than silent genes, glucocorticoids could act through DNA methylation. No change in DNA methylation, however, could be detected during tyrosine aminotransferase induction by glucocorticoids in hepatoma cells, a short-term event (Lapeyre et al., 1980 ). Yet, experiments with MTV-infected lymphoid cells suggest that long-term treatment with glucocorticoids could lead to demethylation of the induced gene, and this might play a role in cell differentiation events induced by these hormones (Mermod et al., 1983) . In any case, glucocorticoids induce the non-methylated transfected forms of MTV, but not their methylated endogenous forms (Groner et al., 1983b (Tymoczko et al., 1983; Rossini & Barbiroli, 1983) . This effect can be reversed by a cytosolic ribonuclease-sensitive factor (Hutchens et al., 1982) or by-purified RNA (Chong & Lippman, 1982) . Preliminary data from our laboratory (I. V. Economidis & G. G. Rousseau, unpublished work) suggest that the receptor can occur as a ribonucleoprotein particle. One interpretation is that the DNA binding site in 'untransformed' receptor is protected by an RNA molecule. One might also imagine that this RNA allows receptor translocation across the nuclear membrane, much in the same way as the RNA-containing 'signal recognition particle' participates in injection of secretory proteins into the endoplasmic reticulum. Another possibility is that DNA recognition by the receptor involves a receptor-associated RNA molecule. Alternatively, the putative receptor-associated RNA might play a role in the post-transcriptional effects of the receptor, such as mRNA stabilization. Clarification of these speculative but exciting issues (small RNAs can behave as biochemical catalysts; see Altman, 1984) obviously requires further characterization of this RNA.
Involvement of chromatin
MTV-infected rat hepatoma cells, containing a single copy of the provirus stably integrated into their DNA, may or may not respond to glucocorticoids by increased MTV transcription (Ucker et al., 1981 (Ucker et al., , 1983 . This points to the importance, for hormone action, of the site of retrovirus integration and, presumably, of chromatin conformation. This is consistent with the observation (Andre et al., 1980) that in the normal host (mouse mammary tumour) cell, mild nuclease treatment of the nuclei preferentially releases the receptor together with a small proportion of MTV DNA. This fraction, containing the few glucocorticoidsensitive copies of MTV DNA, would correspond to 'active chromatin'. Enrichment of the active chromatin fraction in receptors and inducible (i.e. somatotropin) genes has also been reported in pituitary cells (Levy-Wilson, 1983) .
Thus, a hormone-sensitive gene might be rendered insensitive by an unfavourable chromatin enrichment. Such a mechanism has been proposed to explain the loss of glucocorticoid inducibility of the metallothionein gene once it has been amplified in mouse sarcoma cells by selection for resistance to cadmium , or after it has been transfected as recombinant DNA into human or mouse cells . Interestingly, the amplified or transfected gene is still inducible by heavy metals. Butyrate, which inhibits histone deacetylase (but also histone acetyltransferase) and alters chromatin structure, reversibly reduces the accumulation of tyrosine aminotransferase mRNA seen in response to glucocorticoids, without affecting the basal levels (Tichonicky et al., 1981) . Plesko et al. (1983) have shown that this short-term inhibitory effect of butyrate on transcription is specific for a few mRNA species, most of which are glucocorticoidinducible. Moreover this was correlated with inhibition (not stimulation) of the rapid form of histone acetylation, which is compatible with the notion that this form of acetylation 'opens' chromatin structure around steroid-sensitive genes.
Chromatin, in turn, might be functionally altered as a result of glucocorticoid action. Glucocorticoids increase within 2h the phosphorylation of H2A histones in intact mouse cells (Prentice et al., 1978) . In intact rat pituitary cells, human skin fibroblasts, and mouse lymphoma cells, glucocorticoids alter within 15min chromatin structure, as revealed by a change in the number of initiation sites of E. coli RNA polymerase assayed under cellfree conditions (Johnson et al., 1979) . Depending on the metabolic state of the cell, this number is increased or decreased, and gene expression is respectively increased or decreased, by glucocorticoids. This suggests that the receptor might act enzymically. Glucocorticoids decrease within 15 min the number of endogenous ADP-ribose moieties on the non-histone high-mobility-group 14 and 17 proteins in mouse mammary tumour cells. This is concomitant with the hormonal stimulation of MTV RNA synthesis in these cells. Since these proteins are associated with actively transcribed genes, it is likely that ADP-ribosylation of chromosomal proteins. serves as a negative regulator for MTV gene expression and that glucocorticoid action involves a change in ADP-ribose metabolism (Tanuma et al., 1983) .
Whatever the respective role of nucleic acids and chromatin proteins in glucocorticoid regulation of gene transcription, the mechanism of action of the glucocorticoid-receptor complex must account for several puzzling observations. First, glucocorticoids may increase mRNA by acting synergistically with other hormones (Table 1) as is the case for induction of somatotropin mRNA by glucocorticoid and thyroid hormone in cultured pituitary cells (Wegnez et al., 1982) . Moreover, in these cells, a given gene product can be regulated by one hormone but not the other, or by the two hormones in one of three ways: co-induction, corepression or induction by one hormone and repression by the other (Ivarie et al., 1980 (Ivarie et al., , 1982 Fig. 4 . Co-ordinated differences in glucocorticoid control of gene expression in rat hepatoma cell variants Rat hepatoma (HTC) cells in monolayer cultures were exposed to 0.5 !M-dexamethasone (filled bars) or the vehicle, ethanol (open bars) for 48 h, following which specific enzyme activity (mean+S.E.M. for three samples) was determined as described elsewhere (Rousseau et al., 1980) . The tyrosine aminotransferase-inducible variants HMOA and 99 were kindly provided by Dr. P. Mamont. The variants 268EC and 714H, non-inducible for tyrosine aminotransferase, were kindly provided by Dr E. B. Thompson. (G. G. Rousseau, unpublished work.) Also, the same gene product (e.g. phosphoenolpyruvate carboxykinase) can be stimulated in one tissue (the liver) and inhibited in another (white adipose tissue) by glucocorticoids (Feldman, 1977) .
Another phenomenon is the co-ordinate regulation of the glucocorticoid 'domain of response'. In rat hepatoma cells, pharmacological and genetic data show that induction of tyrosine aminotransferase, glutamine synthetase, glycoprotein Belt I, and MTV is mediated by a single glucocorticoid stimulation pathway (Vannice et al., 1983) . Interestingly, loss of inducibility of one gene product (e.g. tyrosine aminotransferase) can be accompanied by 'constitutive' expression of another inducible (e.g. alkaline phosphodiesterase I) gene product (Fig. 4 ).
Summary and conclusions
Glucocorticoids control the expression of a small number of transcriptionally active genes by increasing or decreasing mRNA concentration. Either effect can result from a transcriptional or a post-transcriptional mechanism. Induction of mouse mammary tumour virus RNA results from a stimulation of transcription initiation and depends on the presence of defined regions in proviral DNA. These regions bind the glucocorticoid receptor and behave functionally as protoenhancers. Glucocorticoid-inducible genes can retain their sensitivity to the hormone after transfer to a heterologous cell by transfection techniques. Non-inducible genes can become inducible when linked to the promoter region of an inducible gene.
The mechanisms by which the receptor-steroid complex stimulates or inhibits transcription or influences mRNA stability are unknown. Receptor binding to nucleic acids appears to be a necessary but not sufficient condition. It is likely that the receptor also interacts with chromatin proteins. This might lead to a catalytic modification of these proteins, resulting in a modulation of gene expression. Development of glucocorticoidsensitive, biochemically defined, cell-free transcription systems should provide a tool to delineate the molecular determinants of this essential regulatory mechanism.
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